| Hans-Günter Meyer-Thompson | Verschiedene
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.
Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB, for the American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments.
JAMA Psychiatry. 2017;74(4):399-405. doi:10.1001/jamapsychiatry.2017.0080
Abstract
http://jamanetwork.com/journals/jamapsychiatry/article-abstract/2605202